Mullen Jeffrey, Alrasheed Khalid, Mozaffar Tahseen
Department of Neurology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Pathology and Laboratory Medicine, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Front Neurol. 2022 Oct 18;13:1002310. doi: 10.3389/fneur.2022.1002310. eCollection 2022.
GNE myopathy is an ultrarare muscle disease characterized by slowly progressive muscle weakness. Symptoms typically start in early adulthood, with weakness and atrophy in the tibialis anterior muscles and with slow progression over time, which largely spares the quadriceps muscles. Muscle biopsy shows atrophic fibers and rimmed vacuoles without inflammation. Inherited in an autosomal recessive manner, patients with GNE myopathy carry mutations in the GNE gene which affect the sialic acid synthesis pathway. Here, we look at the history and clinical aspects of GNE myopathy, as well as focus on prior treatment trials and challenges and unmet needs related to this disorder.
GNE肌病是一种极为罕见的肌肉疾病,其特征为缓慢进展的肌肉无力。症状通常始于成年早期,表现为胫前肌无力和萎缩,且随时间缓慢进展,股四头肌基本不受影响。肌肉活检显示萎缩纤维和镶边空泡,无炎症表现。GNE肌病以常染色体隐性方式遗传,患者的GNE基因发生突变,影响唾液酸合成途径。在此,我们探讨GNE肌病的病史和临床情况,同时关注既往治疗试验以及与该疾病相关的挑战和未满足的需求。